K. Fearon, F. Strasser, S. D. Anker, I. Bosaeus, E. Bruera et al., Definition and classification of cancer cachexia: an international consensus, Lancet Oncol, vol.12, issue.5, pp.489-95, 2011.

A. Laviano, M. M. Meguid, A. Inui, M. Muscaritoli, and F. Rossi-fanelli, Therapy insight: cancer anorexia-cachexia syndrome -when all you can eat is yourself, Nat Clin Prac Oncol, vol.2, issue.3, pp.158-65, 2005.

K. Fearon, J. Arends, and V. Baracos, Understanding the mechanisms and treatment options in cancer cachexia, Nat Rev Clin Oncol, vol.10, issue.2, pp.90-99, 2013.

H. Suzuki, A. Asakawa, H. Amitani, N. Nakamura, and A. Inui, Cancer cachexia -pathophysiology and management, J Gastroenterol, vol.48, issue.5, pp.574-94, 2013.

D. Osoba, B. Zee, D. Warr, L. Kaizer, J. Latreille et al., Quality of life studies in chemotherapy-induced emesis, Oncology, issue.1, pp.92-97, 1996.

S. T. Sonis, Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity, Oral Oncol, vol.34, issue.1, pp.39-43, 1998.

N. M. Blijlevens, Implications of treatment-induced mucosal barrier injury, Curr Opin Oncol, vol.17, issue.6, pp.605-615, 2005.

M. Hofman, G. R. Morrow, J. A. Roscoe, J. T. Hickok, K. M. Mustian et al., Cancer patients' expectations of experiencing treatment-related side effects, Cancer, vol.101, issue.4, pp.851-858, 2004.

P. Gordon, S. B. Legrand, and D. Walsh, Nausea and vomiting in advanced cancer, Eur J Pharmacol, vol.722, pp.187-91, 2014.

L. Bricon, T. Gugins, S. Cynober, L. Baracos, and V. E. , Negative impact of cancer chemotherapy on protein metabolism in healthy and tumor-bearing rats, Metabolism, vol.44, issue.10, pp.1340-1348, 1995.

M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo et al., Ghrelin is a growth-hormone-releasing acylated peptide from stomach, Nature, vol.402, issue.6762, pp.656-60, 1999.

M. Nakazato, N. Murakami, Y. Date, M. Kojima, H. Matsuo et al., A role for ghrelin in the central regulation of feeding, Nature, vol.409, issue.6817, pp.194-202, 2001.

M. Satou, Y. Nishi, J. Yoh, Y. Hattori, and H. Sugimoto, Identification and characterization of acyl-protein thioesterase 1/lysophospholipase I as a ghrelin deacylation/lysophospholipid hydrolyzing enzyme in fetal bovine serum and conditioned medium, Endocrinology, issue.10, pp.4765-75, 2010.

H. Hosoda, M. Kojima, H. Matsuo, and K. Kangawa, Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue, Biochem Biophys Res Commun, vol.279, issue.3, pp.909-922, 2000.

T. D. Müller and M. H. Tschöp, Ghrelin -a key pleiotropic hormone-regulating systemic energy metabolism, Endocr Dev, vol.25, pp.91-100, 2013.

J. C. Chuang and J. M. Zigman, Ghrelin's roles in stress, mood, and anxiety regulation, Int J Pept, p.460549, 2010.

M. Lutter, I. Sakata, S. Osborne-lawrence, S. A. Rovinsky, J. G. Anderson et al., The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress, Nat Neurosci, vol.11, issue.7, pp.752-755, 2008.

S. J. Spencer, L. Xu, M. A. Clarke, M. Lemus, A. Reichenbach et al., Ghrelin regulates the hypothalamic-pituitary-adrenal axis and restricts anxiety after acute stress, Biol Psychiatry, vol.72, issue.6, pp.457-65, 2012.

T. Akamizu and K. Kangawa, Ghrelin for cachexia, J Cachexia Sarcopenia Muscle, vol.1, issue.2, pp.169-76, 2010.

N. Fujitsuka, A. Asakawa, Y. Uezono, K. Minami, T. Yamaguchi et al., Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival, Transl Psychiatry, vol.1, 2011.

C. Pietra, Y. Takeda, N. Tazawa-ogata, M. Minami, X. Yuanfeng et al., Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile, J Cachexia Sarcopenia Muscle, vol.5, issue.4, pp.329-366, 2014.

H. Takeda, C. Sadakane, T. Hattori, T. Katsurada, T. Ohkawara et al., an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism, Gastroenterology, vol.134, issue.7, pp.2004-2017, 2008.

Y. Hiura, S. Takiguchi, K. Yamamoto, Y. Kurokawa, M. Yamasaki et al., Fall in plasma ghrelin concentrations after cisplatin-based chemotherapy in esophageal cancer patients, Int J Clin Oncol, vol.17, issue.4, pp.316-339, 2012.

Y. Hiura, S. Takiguchi, K. Yamamoto, T. Takahashi, Y. Kurokawa et al., Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients, Cancer, vol.118, pp.4785-94, 2012.

S. Perboni, C. Bowers, S. Kojima, A. Asakawa, and A. Inui, Growth hormone releasing peptide 2 reverses anorexia associated with chemotherapy with 5-fluoruracil in colon cancer cell-bearing mice, World J Gastroenterol, vol.14, issue.41, pp.6303-6308, 2008.

G. S. Longo-sorbello and J. R. Bertino, Current understanding of methotrexate pharmacology and efficacy in acute leukemias. Use of newer antifolates in clinical trials, Haematologica, vol.86, issue.2, pp.121-128, 2001.

J. Leblond, L. Pessot, F. Hubert-buron, A. Duclos, C. Vuichoud et al., Chemotherapy-induced mucositis is associated with changes in proteolytic pathways, Exp Biol Med (Maywood), vol.233, issue.2, pp.219-247, 2008.

N. Boukhettala, J. Leblond, S. Claeyssens, M. Faure, L. Pessot et al., Methotrexate induces intestinal mucositis and alters gut protein metabolism independently of reduced food intake, Am J Physiol Endocrinol Metab, vol.296, issue.1, 2009.

I. Alamir, N. Boukhettala, M. Aziz, D. Breuillé, P. Déchelotte et al., Beneficial effects of cathepsin inhibition to prevent chemotherapy-induced intestinal mucositis, Clin Exp Immunol, vol.162, issue.2, pp.298-305, 2010.

S. Beutheu, W. Ouelaa, C. Guérin, L. Belmonte, M. Aziz et al., Glutamine supplementation, but not combined glutamine and arginine supplementation, improves gut barrier function during chemotherapy-induced intestinal mucositis in rats, Clin Nutr, vol.33, issue.4, pp.694-701, 2014.

H. Sinno, M. Coquerel, Q. Boukhettala, N. Coëffier, M. Gallas et al., Chemotherapy-induced anorexia is accompanied by activation of brain pathways signaling dehydration, Physiol Behav, vol.101, pp.639-687, 2010.

K. Takagi, R. Legrand, A. Asakawa, H. Amitani, M. François et al., Anti-ghrelin immunoglobulins modulate ghrelin stability and its orexigenic effect in obese mice and humans, Nat Commun, vol.4, p.2685, 2013.

Q. Coquerel, H. Sinno, M. Boukhettala, N. Coëffier, M. Terashi et al., Intestinal inflammation influences ?-MSH reactive autoantibodies: relevance to food intake and body weight, Psychoneuroendocrinology, vol.37, pp.94-106, 2012.

K. R. Bailey and J. N. Crawley, Methods of Behavior Analysis in Neuroscience, 2009.

S. O. Fetissov, Neuropeptide autoantibodies assay, Methods Mol Biol, vol.789, pp.295-302, 2011.

R. Legrand, K. Takagi, and S. O. Fetissov, Immunoglobulin G preparation from plasma samples and analysis of its affinity kinetic binding to peptide hormones, 2014.

T. Shiiya, M. Nakazato, M. Mizuta, Y. Date, M. S. Mondal et al., Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion, J Clin Endocrinol Metab, vol.87, issue.1, pp.240-244, 2002.

V. Coiro, G. Saccani-jotti, P. Rubino, G. Manfredi, P. Vacca et al., Oxytocin inhibits the stimulatory effect of ghrelin on circulating neuropeptide Y levels in humans, J Neural Transm, vol.115, issue.9, pp.1265-1272, 2008.

D. Atasoy, J. N. Betley, H. H. Su, and S. M. Sternson, Deconstruction of a neural circuit for hunger, Nature, vol.488, issue.7410, pp.172-179, 2012.

J. Nedvídková, I. Krykorková, V. Barták, H. Papezová, P. W. Gold et al., Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa, J Clin Endocrinol Metab, vol.88, issue.4, pp.1678-82, 2003.

M. Misra, K. K. Miller, K. Kuo, K. Griffin, V. Stewart et al., Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents, Am J Physiol Endocrinol Metab, vol.289, issue.3, pp.347-56, 2004.

V. Tolle, M. Kadem, M. Bluet-pajot, D. Frere, C. Foulon et al., Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women, J Clin Endocrinol Metab, vol.88, issue.1, pp.109-125, 2003.

N. Germain, B. Galusca, D. Grouselle, D. Frere, V. Tolle et al., Ghrelin/ obestatin ratio in two populations with low body weight: constitutional thinness and anorexia nervosa, Psychoneuroendocrinology, vol.34, issue.3, pp.413-422, 2009.

J. L. Goldstein, T. Zhao, R. L. Li, D. P. Sherbet, G. Liang et al., Surviving starvation: essential role of the ghrelin-growth hormone axis, Cold Spring Harb Symp Quant Biol, vol.76, pp.121-128, 2011.

L. Verhagen, E. Egecioglu, M. Luijendijk, J. Hillebrand, R. Adan et al., Acute and chronic suppression of the central ghrelin signaling system reveals a role in food anticipatory activity, Eur Neuropsychopharmacol, vol.21, issue.5, pp.384-92, 2011.

M. Méquinion, E. Caron, S. Zgheib, A. Stievenard, P. Zizzari et al., Physical activity: benefit or weakness in metabolic adaptations in a mouse model of chronic food restriction?, Am J Physiol, vol.308, issue.3, pp.241-55, 2015.

R. Legrand, N. Lucas, J. Breton, S. Azhar, J. Do-rego et al., Ghrelin treatment prevents development of activity based anorexia in mice, Eur Neuropsychopharmacol, vol.26, issue.6, pp.948-58, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02295806

M. François, S. Barde, N. Achamrah, J. Breton, J. Do-rego et al., The number of preproghrelin mRNA expressing cells is increased in mice with activity-based anorexia, Neuropeptides, vol.51, pp.17-23, 2015.

J. Yang, M. S. Brown, G. Liang, N. V. Grishin, and J. L. Goldstein, Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone, Cell, vol.132, issue.3, pp.387-96, 2008.

Y. Shanado, M. Kometani, H. Uchiyama, S. Koizumi, and N. Teno, Lysophospholipase I identified as a ghrelin deacylation enzyme in rat stomach, Biochem Biophys Res Commun, vol.325, issue.4, pp.1487-94, 2004.

M. François, S. Barde, R. Legrand, N. Lucas, S. Azhar et al., Highfat diet increases ghrelin-expressing cells in stomach, contributing to obesity, Nutrition, vol.32, issue.6, pp.709-724, 2016.

M. Terashi, A. Asakawa, T. Harada, M. Ushikai, Q. Coquerel et al., Ghrelin reactive autoantibodies in restrictive anorexia nervosa, Nutrition, vol.27, issue.4, pp.407-420, 2011.

R. Dantzer, M. W. Meagher, and C. S. Cleeland, Translational approaches to treatment-induced symptoms in cancer patients, Nat Rev Clin Oncol, vol.9, issue.7, pp.414-440, 2012.

M. Pandey, G. Sarita, D. N. Thomas, B. Hussain, B. Krishnan et al., Distress, anxiety, and depression in cancer patients undergoing chemotherapy, World J Surg Oncol, vol.4, issue.1, p.68, 2006.

D. Mastro, L. Costantini, M. Morasso, G. Bonci, F. Bergaglio et al., Impact of two different dose-intensity chemotherapy regimens on psychological distress in early breast cancer patients, Eur J Cancer, vol.38, issue.3, pp.359-66, 2002.

E. Haroon, C. L. Raison, and A. H. Miller, Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior, Neuropsychopharmacology, vol.37, issue.1, pp.137-62, 2012.

R. A. Luna and J. A. Foster, Gut brain axis: diet microbiota interactions and implications for modulation of anxiety and depression, Curr Opin Biotechnol, vol.32, pp.35-41, 2015.

S. O. Fetissov and P. Déchelotte, The new link between gut-brain axis and neuropsychiatric disorders, Curr Opin Clin Nutr Metab Care, vol.14, issue.5, pp.477-82, 2011.

M. François, J. M. Schaefer, C. Bole-feysot, P. Déchelotte, F. C. Verhulst et al., Ghrelin-reactive immunoglobulins and anxiety, depression